Female ‘viagra’ raises safety concerns

Published



The first-ever female libido drug might not mix well with alcohol or other medications, a new report suggests.

Advisers to the Food and Drug Administration will meet Thursday to weigh safety concerns with flibanserin, a pill that, if approved, would be the first drug to treat low female sexual interest and arousal.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.